Virpax Pharmaceuticals Inc (VRPX) concluded trading on Thursday at a closing price of $0.29, with 20.86 million shares of worth about $6.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -65.97% during that period and on February 13, 2025 the price saw a gain of about 7.64%. Currently the company’s common shares owned by public are about 18.34M shares, out of which, 18.04M shares are available for trading.
Stock saw a price change of 6.25% in past 5 days and over the past one month there was a price change of -17.22%. Year-to-date (YTD), VRPX shares are showing a performance of -23.95% which decreased to -91.96% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.23 but also hit the highest price of $5.48 during that period. The average intraday trading volume for Virpax Pharmaceuticals Inc shares is 3.89 million. The stock is currently trading -1.10% below its 20-day simple moving average (SMA20), while that difference is down -13.86% for SMA50 and it goes to -63.29% lower than SMA200.
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) currently have 18.34M outstanding shares and institutions hold larger chunk of about 0.73% of that.
The stock has a current market capitalization of $5.30M and its 3Y-monthly beta is at 0.93. It has posted earnings per share of -$8.82 in the same period. It has Quick Ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VRPX, volatility over the week remained 9.98% while standing at 10.59% over the month.
Analysts are in expectations that Virpax Pharmaceuticals Inc (VRPX) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
